$695 Million is the total value of Octagon Capital Advisors LP's 36 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $214,370,000 | +31.2% | 3,250,000 | +2.8% | 30.84% | +21.2% |
| KDNY | CHINOOK THERAPEUTICS INC | $59,071,924 | -11.6% | 2,551,703 | 0.0% | 8.50% | -18.4% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $49,557,440 | -23.2% | 2,468,000 | 0.0% | 7.13% | -29.0% | |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $39,858,405 | +241.9% | 4,570,918 | +145.9% | 5.74% | +216.0% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $39,617,280 | -22.8% | 2,172,000 | -12.5% | 5.70% | -28.7% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $30,146,400 | +25.2% | 1,185,000 | +43.8% | 4.34% | +15.7% |
| New | ROIVANT SCIENCES LTD | $28,811,520 | – | 3,904,000 | +100.0% | 4.14% | – | |
| MRTX | MIRATI THERAPEUTICS INC | $27,885,000 | -17.9% | 750,000 | 0.0% | 4.01% | -24.2% | |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $27,341,130 | -19.4% | 759,898 | -0.2% | 3.93% | -25.5% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $22,186,693 | +211.8% | 1,338,160 | +43.3% | 3.19% | +188.1% |
| TNDM | TANDEM DIABETES CARE INC | $19,286,867 | -9.7% | 474,929 | 0.0% | 2.78% | -16.5% | |
| AVTE | AEROVATE THERAPEUTICS INC | $12,539,931 | -31.2% | 621,712 | 0.0% | 1.80% | -36.4% | |
| New | JASPER THERAPEUTICS INC | $11,552,325 | – | 6,382,500 | +100.0% | 1.66% | – | |
| TVTX | New | TRAVERE THERAPEUTICS INC | $11,132,550 | – | 495,000 | +100.0% | 1.60% | – |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $9,279,440 | +3.1% | 1,202,000 | -1.9% | 1.34% | -4.8% |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $8,594,931 | -22.6% | 499,996 | 0.0% | 1.24% | -28.5% | |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $8,111,560 | -6.7% | 596,000 | +33.9% | 1.17% | -13.7% |
| DYN | New | DYNE THERAPEUTICS INC | $7,982,726 | – | 692,945 | +100.0% | 1.15% | – |
| XILIO THERAPEUTICS INC | $7,687,250 | +17.8% | 2,425,000 | 0.0% | 1.11% | +8.9% | ||
| VKTX | Sell | VIKING THERAPEUTICS INC | $6,243,750 | -23.7% | 375,000 | -56.9% | 0.90% | -29.5% |
| VERA | Buy | VERA THERAPEUTICS INCcl a | $6,169,200 | -52.1% | 795,000 | +19.5% | 0.89% | -55.7% |
| ETNB | Buy | 89BIO INC | $6,092,000 | +25.9% | 400,000 | +5.3% | 0.88% | +16.5% |
| RNA | Buy | AVIDITY BIOSCIENCES INC | $5,863,700 | -18.6% | 382,000 | +17.7% | 0.84% | -24.8% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $5,128,005 | -56.1% | 94,700 | -57.1% | 0.74% | -59.5% |
| GERN | New | GERON CORP | $4,943,260 | – | 2,278,000 | +100.0% | 0.71% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $4,667,930 | – | 577,000 | +100.0% | 0.67% | – |
| ANNX | New | ANNEXON INC | $4,581,500 | – | 1,190,000 | +100.0% | 0.66% | – |
| GLYC | New | GLYCOMIMETICS INC | $3,780,000 | – | 3,000,000 | +100.0% | 0.54% | – |
| RPHM | New | RENEO PHARMACEUTICALS INC | $2,511,600 | – | 420,000 | +100.0% | 0.36% | – |
| GOSS | GOSSAMER BIO INC | $2,467,167 | -41.9% | 1,958,069 | 0.0% | 0.36% | -46.4% | |
| New | STRUCTURE THERAPEUTICS INCsponsored ads | $2,228,933 | – | 93,692 | +100.0% | 0.32% | – | |
| BBIO | New | BRIDGEBIO PHARMA INCcall | $1,658,000 | – | 100,000 | +100.0% | 0.24% | – |
| STOK | Sell | STOKE THERAPEUTICS INC | $1,546,623 | -78.1% | 185,669 | -75.7% | 0.22% | -79.7% |
| CNTA | New | CENTESSA PHARMACEUTICALS PLCsponsored ads | $1,524,600 | – | 396,000 | +100.0% | 0.22% | – |
| VECT | New | VECTIVBIO HLDG AG | $300,054 | – | 35,259 | +100.0% | 0.04% | – |
| PIRS | New | PIERIS PHARMACEUTICALS INC | $294,254 | – | 301,490 | +100.0% | 0.04% | – |
| IPSC | Exit | CENTURY THERAPEUTICS INC | $0 | – | -45,000 | -100.0% | -0.04% | – |
| Exit | NUVALENT INC | $0 | – | -25,000 | -100.0% | -0.12% | – | |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCspon ads | $0 | – | -1,000,000 | -100.0% | -0.12% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -1,400,000 | -100.0% | -0.24% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -15,000 | -100.0% | -0.26% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -15,000 | -100.0% | -0.26% | – |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -800,000 | -100.0% | -0.30% | – |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.30% | – |
| XBI | Exit | SPDR SER TRs&p biotech | $0 | – | -199,417 | -100.0% | -2.58% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -1,278,000 | -100.0% | -4.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 33.2% |
| ARCUS BIOSCIENCES INC | 12 | Q3 2023 | 18.1% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 10.1% |
| GOSSAMER BIO INC | 12 | Q3 2023 | 6.2% |
| 4D MOLECULAR THERAPEUTICS IN | 10 | Q1 2023 | 6.6% |
| BRIDGEBIO PHARMA INC | 10 | Q3 2023 | 6.6% |
| AVIDITY BIOSCIENCES INC | 10 | Q1 2023 | 3.8% |
| VERA THERAPEUTICS INC | 9 | Q2 2023 | 3.5% |
| DYNE THERAPEUTICS INC | 9 | Q3 2023 | 3.5% |
| STOKE THERAPEUTICS INC | 9 | Q2 2023 | 3.7% |
View Octagon Capital Advisors LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-05 |
| SC 13G | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-25 |
| 13F-HR | 2022-11-14 |
View Octagon Capital Advisors LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.